These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 32613146

  • 1. Highly Reactive Isolevuglandins Promote Atrial Fibrillation Caused by Hypertension.
    Prinsen JK, Kannankeril PJ, Sidorova TN, Yermalitskaya LV, Boutaud O, Zagol-Ikapitte I, Barnett JV, Murphy MB, Subati T, Stark JM, Christopher IL, Jafarian-Kerman SR, Saleh MA, Norlander AE, Loperena R, Atkinson JB, Fogo AB, Luther JM, Amarnath V, Davies SS, Kirabo A, Madhur MS, Harrison DG, Murray KT.
    JACC Basic Transl Sci; 2020 Jun; 5(6):602-615. PubMed ID: 32613146
    [Abstract] [Full Text] [Related]

  • 2. Isolevuglandins Promote Mitochondrial Dysfunction and Electrophysiologic Abnormalities in Atrial Cardiomyocytes.
    Subati T, Yang Z, Murphy MB, Stark JM, Trykall DZ, Davies SS, Barnett JV, Murray KT.
    Cells; 2024 Mar 09; 13(6):. PubMed ID: 38534327
    [Abstract] [Full Text] [Related]

  • 3. 2-Hydroxybenzylamine (2-HOBA) to prevent early recurrence of atrial fibrillation after catheter ablation: protocol for a randomized controlled trial including detection of AF using a wearable device.
    O'Neill MJ, Yoneda ZT, Crawford DM, Ye F, Ao M, Pitchford LM, Rathmacher JA, Murray KT, Akers WS, Roden DM, Michaud GF, Shoemaker MB.
    Trials; 2021 Aug 28; 22(1):576. PubMed ID: 34454591
    [Abstract] [Full Text] [Related]

  • 4. Reactive γ-ketoaldehydes promote protein misfolding and preamyloid oligomer formation in rapidly-activated atrial cells.
    Sidorova TN, Yermalitskaya LV, Mace LC, Wells KS, Boutaud O, Prinsen JK, Davies SS, Roberts LJ, Dikalov SI, Glabe CG, Amarnath V, Barnett JV, Murray KT.
    J Mol Cell Cardiol; 2015 Feb 28; 79():295-302. PubMed ID: 25463275
    [Abstract] [Full Text] [Related]

  • 5. Natriuretic Peptide Oligomers Cause Proarrhythmic Metabolic and Electrophysiological Effects in Atrial Myocytes.
    Yang Z, Subati T, Kim K, Murphy MB, Dougherty OP, Christopher IL, Van Amburg JC, Woodall KK, Barnett JV, Murray KT.
    Circ Arrhythm Electrophysiol; 2022 Mar 28; 15(3):e010636. PubMed ID: 35212578
    [Abstract] [Full Text] [Related]

  • 6. LNK/SH2B3 loss of function increases susceptibility to murine and human atrial fibrillation.
    Murphy MB, Yang Z, Subati T, Farber-Eger E, Kim K, Blackwell DJ, Fleming MR, Stark JM, Van Amburg JC, Woodall KK, Van Beusecum JP, Agrawal V, Smart CD, Pitzer A, Atkinson JB, Fogo AB, Bastarache JA, Kirabo A, Wells QS, Madhur MS, Barnett JV, Murray KT.
    Cardiovasc Res; 2024 Jul 02; 120(8):899-913. PubMed ID: 38377486
    [Abstract] [Full Text] [Related]

  • 7. Isolevuglandin scavenger attenuates pressure overload-induced cardiac oxidative stress, cardiac hypertrophy, heart failure and lung remodeling.
    Shang L, Weng X, Wang D, Yue W, Mernaugh R, Amarnath V, Weir EK, Dudley SC, Xu Y, Hou M, Chen Y.
    Free Radic Biol Med; 2019 Sep 02; 141():291-298. PubMed ID: 31254620
    [Abstract] [Full Text] [Related]

  • 8. Isolevuglandins Scavenger Ameliorates Myocardial Ischemic Injury by Suppressing Oxidative Stress, Apoptosis, and Inflammation.
    Guo J, Xu F, Ji H, Jing Y, Shen L, Weng X, Hu L.
    Front Cell Dev Biol; 2022 Sep 02; 10():836035. PubMed ID: 35356291
    [Abstract] [Full Text] [Related]

  • 9. Inflammation Biomarker Response to Oral 2-Hydroxybenzylamine (2-HOBA) Acetate in Healthy Humans.
    Rathmacher JA, Fuller JC, Abumrad NN, Flynn CR.
    Inflammation; 2023 Aug 02; 46(4):1343-1352. PubMed ID: 36935449
    [Abstract] [Full Text] [Related]

  • 10. Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr-/- mice.
    Tao H, Huang J, Yancey PG, Yermalitsky V, Blakemore JL, Zhang Y, Ding L, Zagol-Ikapitte I, Ye F, Amarnath V, Boutaud O, Oates JA, Roberts LJ, Davies SS, Linton MF.
    Nat Commun; 2020 Aug 14; 11(1):4084. PubMed ID: 32796843
    [Abstract] [Full Text] [Related]

  • 11. IsoLGs (Isolevuglandins) Drive Neutrophil Migration in Hypertension and Are Essential for the Formation of Neutrophil Extracellular Traps.
    Krishnan J, de la Visitación N, Hennen EM, Amarnath V, Harrison DG, Patrick DM.
    Hypertension; 2022 Aug 14; 79(8):1644-1655. PubMed ID: 35686559
    [Abstract] [Full Text] [Related]

  • 12. Targeting of reactive isolevuglandins in mitochondrial dysfunction and inflammation.
    Mayorov V, Uchakin P, Amarnath V, Panov AV, Bridges CC, Uzhachenko R, Zackert B, Moore CS, Davies S, Dikalova A, Dikalov S.
    Redox Biol; 2019 Sep 14; 26():101300. PubMed ID: 31437812
    [Abstract] [Full Text] [Related]

  • 13. Mitochondrial Isolevuglandins Contribute to Vascular Oxidative Stress and Mitochondria-Targeted Scavenger of Isolevuglandins Reduces Mitochondrial Dysfunction and Hypertension.
    Dikalova A, Mayorov V, Xiao L, Panov A, Amarnath V, Zagol-Ikapitte I, Vergeade A, Ao M, Yermalitsky V, Nazarewicz RR, Boutaud O, Lopez MG, Billings FT, Davies S, Roberts LJ, Harrison DG, Dikalov S.
    Hypertension; 2020 Dec 14; 76(6):1980-1991. PubMed ID: 33012204
    [Abstract] [Full Text] [Related]

  • 14. Biomarkers for predicting atrial fibrillation: An explorative sub-analysis of the randomised SCREEN-AF trial.
    Schmalstieg-Bahr K, Gladstone DJ, Hummers E, Suerbaum J, Healey JS, Zapf A, Köster D, Werhahn SM, Wachter R.
    Eur J Gen Pract; 2024 Dec 14; 30(1):2327367. PubMed ID: 38497412
    [Abstract] [Full Text] [Related]

  • 15. Electrophilic reactive aldehydes as a therapeutic target in colorectal cancer prevention and treatment.
    Gobert AP, Asim M, Smith TM, Williams KJ, Barry DP, Allaman MM, McNamara KM, Hawkins CV, Delgado AG, Zhao S, Piazuelo MB, Washington MK, Coburn LA, Rathmacher JA, Wilson KT.
    Oncogene; 2023 May 14; 42(20):1685-1691. PubMed ID: 37037901
    [Abstract] [Full Text] [Related]

  • 16. Hypertension is associated with preamyloid oligomers in human atrium: a missing link in atrial pathophysiology?
    Sidorova TN, Mace LC, Wells KS, Yermalitskaya LV, Su PF, Shyr Y, Atkinson JB, Fogo AB, Prinsen JK, Byrne JG, Petracek MR, Greelish JP, Hoff SJ, Ball SK, Glabe CG, Brown NJ, Barnett JV, Murray KT.
    J Am Heart Assoc; 2014 Dec 02; 3(6):e001384. PubMed ID: 25468655
    [Abstract] [Full Text] [Related]

  • 17. Isolevuglandins (isoLGs) as toxic lipid peroxidation byproducts and their pathogenetic role in human diseases.
    Aschner M, Nguyen TT, Sinitskii AI, Santamaría A, Bornhorst J, Ajsuvakova OP, da Rocha JBT, Skalny AV, Tinkov AA.
    Free Radic Biol Med; 2021 Jan 02; 162():266-273. PubMed ID: 33099003
    [Abstract] [Full Text] [Related]

  • 18. Immunoproteasomal Processing of Isolevuglandin Adducts in Hypertension.
    de la Visitación N, Chen W, Krishnan J, Van Beusecum JP, Amarnath V, Hennen EM, Zhao S, Saleem M, Ao M, Harrison DG, Patrick DM.
    bioRxiv; 2023 Apr 12. PubMed ID: 37383945
    [Abstract] [Full Text] [Related]

  • 19. The influence of left ventricle diastolic function on natriuretic peptides levels in patients with atrial fibrillation.
    Bakowski D, Wozakowska-Kaplon B, Opolski G.
    Pacing Clin Electrophysiol; 2009 Jun 12; 32(6):745-52. PubMed ID: 19545336
    [Abstract] [Full Text] [Related]

  • 20. Chronic B-Type Natriuretic Peptide Therapy Prevents Atrial Electrical Remodeling in a Rabbit Model of Atrial Fibrillation.
    Zhao H, Li T, Liu G, Zhang L, Li G, Yu J, Lou Q, He R, Zhan C, Li L, Yang W, Zang Y, Cheng C, Li W.
    J Cardiovasc Pharmacol Ther; 2019 Nov 12; 24(6):575-585. PubMed ID: 31159577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.